Long‐term effects of discontinuing renin–angiotensin system inhibitors in COVID‐19

Saved in:
Bibliographic Details
Published inRespirology (Carlton, Vic.) Vol. 27; no. 9; pp. 788 - 790
Main Authors Theurl, Fabian, Sappler, Nikolay, Rizas, Konstantinos D., Massberg, Steffen, Bauer, Axel, Schreinlechner, Michael
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.09.2022
Wiley Subscription Services, Inc
Subjects
Angiotensin
antihypertensive drugs
Correspondence
COVID-19
hypertension
Renin
renin–angiotensin‐system inhibitors (RASi)
Respiratory diseases
SARS‐CoV‐2
COVID-19
antihypertensive drugs
SARS-CoV-2
hypertension
renin-angiotensin-system inhibitors (RASi)
Online AccessGet full text

Cover

More Information
Bibliography:Funding information
Austrian Science Fund, Grant/Award Number: KLI‐900; Deutsches Zentrum für Herz‐Kreislaufforschung, Grant/Award Number: ACEI‐COVID
Philip Bardin
Handling Editor
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
Funding information Austrian Science Fund, Grant/Award Number: KLI‐900; Deutsches Zentrum für Herz‐Kreislaufforschung, Grant/Award Number: ACEI‐COVID
Handling Editor: Philip Bardin
ISSN:1323-7799
1440-1843
DOI:10.1111/resp.14306